Angle Closure (Glaucoma) in Caucasians
Structural and Functional Parameters in Caucasian Patients With Angle Closure on SS-OCT
1 other identifier
observational
100
1 country
1
Brief Summary
Rationale: Primary angle closure glaucoma (PACG) causes high rates of blindness, either by means of a painful attack of acute angle closure glaucoma or unnoticed over a period of many years. Patients with angle closure are particularly at risk but can be detected during an ophthalmological examination and sent for early preventive (laser) intervention. Current practice shows that patients at risk of PACG are frequently missed during routine examinations. Moreover, new imaging techniques like swept source optical coherence tomography (SS-OCT), are emerging with which the angle of the anterior chamber can be imaged in great detail with no burden for the patient. These techniques are already used in clinical practice and replace and complete part of the ophthalmic examination. However, in Caucasians, it is not yet known to what extent angle closure is detected in regular care and can be detected with this OCT device. There are few published data concerning angle closure and PACG in Caucasians and its characteristics. Objective: To quantify the presence of angle closure by gonioscopy in patients at risk of angle closure on SS-OCT. Secondary objectives are to quantify the presence of an increased intra-ocular pressure during the day or after dark provocation, to quantify morphometric details of the anterior chamber, structural changes, and corneal endothelial cells and to quantify the functional changes of the visual field. Study design: prospective, observational, descriptive study. Study population: Caucasian patients, presenting at the outpatient clinic of the University Eye Clinic Maastricht, aged 40 to 80 years, who are diagnosed with angle closure on SS-OCT. Intervention (if applicable): Not applicable. Main study parameters/endpoints: The main study parameter is assessment of the anterior chamber angle according to gonioscopy. Secondary study parameters are the presence of an increased intra-ocular pressure (IOP) (\>21 mmHg) during the day or after dark provocation (IOP rise from baseline), morphometric details of the anterior chamber, structural changes of the retinal nerve fiber layer, number of corneal endothelial cells and functional changes of the visual field Hypothesis: It is hypothesised that, based on its resolution and ease of use, SS-OCT is a suitable imaging technique to identify patients with or at risk of angle closure. It will be of value as an additional diagnostic instrument and may even replace gonioscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2014
CompletedFirst Posted
Study publicly available on registry
February 4, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFebruary 4, 2014
February 1, 2014
1 year
January 30, 2014
February 3, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Angle closure on gonioscopy
The percentage of subjects with angle closure on gonioscopy compared with angle closure on SS-OCT.
3 weeks
Secondary Outcomes (1)
intra-ocular pressure (IOP)
3 weeks
Other Outcomes (5)
Visual field loss
3 weeks
Retinal nerve fiber layer thickness
3 weeks
Number of corneal endothelial cells
3 weeks
- +2 more other outcomes
Study Arms (1)
angle closure
Eligibility Criteria
This study will consist of Caucasian patients, aged 40-80 years. Patients will be recruited at the University Eye Clinic Maastricht, the Netherlands. All study participants are derived from the study 'Caucasian patients with angle closure on SS-OCT', METC 13-4-108.
You may qualify if:
- Caucasian race
- years
- Willing and able to comply with scheduled visits and other study procedures
- Signed informed consent
- Participants derived from the study 'Caucasian patients with angle closure on SS-OCT' AND 1 or more of the following:
- Irido-trabecular contact (ITC) in ≥2 quadrants as seen with SS-OCT in darkened conditions
- Scleral spur angle (SSA) \<20˚ (in 0 and 180º) AND anterior chamber depth (ACD) \< 2.5 mm as seen with SS-OCT in darkened conditions
- The fellow, non-treated eye in a patient after an acute primary angle closure (APAC) attack in the other eye. APAC is defined as an abrupt onset of symptomatic elevation of IOP resulting from total closure of the angle which is typically not self-limiting (although acute attacks can rarely resolve spontaneously).
You may not qualify if:
- Any condition including (previous) intraocular laser/incisional surgery or medical procedure or treatment in ophthalmology
- Any eye condition/abnormality that will affect the acquisition/reliability of measurement (results), (e.g. vitreous haemorrhage, uveitis, intraocular trauma, significant corneal opacity)
- Unable to communicate properly or to understand instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Eye Clinic Maastricht
Maastricht, 6202AZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2014
First Posted
February 4, 2014
Study Start
April 1, 2014
Primary Completion
April 1, 2015
Study Completion
October 1, 2015
Last Updated
February 4, 2014
Record last verified: 2014-02